患有活跃和晚期恶性病的患者的心血管干预:更新的综述
Fahad Waqar1, Ayesha Sultan1, Romeet R Bathija1
1Department of Cardiovascular Analytics Group, Islamabad, Pakistan.
Journal of community hospital internal medicine perspectives
|October 11, 2024
概括
本综述考察了晚期癌症患者的侵袭性心脏干预,考虑了独特的风险和生存预期. 它旨在指导临床医生为复杂的癌症和心血管疾病病例做出明智的治疗决策.
科学领域:
- 心脏病学和瘤学
- 干预心脏病学 干预心脏病学
- 癌症的生存率 癌症的生存率
背景情况:
- 对侵袭性心脏干预的证据通常不包括患有晚期恶性瘤的患者.
- 癌症和心血管疾病的交叉带来了独特的治疗挑战.
- 关于心脏手术在活跃,晚期癌症患者的疗效和安全性的数据有限.
研究的目的:
- 在患有活跃,晚期癌症的患者中全面审查侵入性心脏干预.
- 在这个人群中分析各种心血管疾病中程序的适用性.
- 提供关于癌症患者心脏干预的临床决策框架.
主要方法:
- 对晚期癌症患者的侵袭性心脏干预的系统性文献综述.
- 分析心血管疾病,包括心肌梗塞,冠状动脉疾病,大动脉狭窄和心肌病.
- 对各种晚期恶性瘤的当代生存预期的评估.
主要成果:
- 侵袭性心脏干预主要基于不包括晚期癌症患者的试验证据.
- 在晚期恶性瘤中进行心脏手术的好处和风险需要仔细考虑.
- 竞争性癌症死亡率影响治疗建议.
结论:
- 对于活跃的,晚期癌症的侵袭性心脏干预需要一个细微的方法.
- 了解癌症预后对于评估心脏干预的适当性至关重要.
- 本综述为管理复杂癌症和心血管疾病的临床医生提供了指导.
相关概念视频
Cardiomyopathy V: Interprofessional Care
2
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
2
Cardiomyopathy VI: Nursing Management
2
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
2
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cardiomyopathy II: Dilated Cardiomyopathy
1
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
Heart Failure V: Nursing Interventions
2
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
2
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


